Search Results - "Hurley, Michael J"
-
1
Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson’s Disease: Therapeutic Rationale and Current Status
Published in CNS drugs (01-12-2016)“…Parkinson’s disease is a disabling hypokinetic neurological movement disorder in which the aetiology is unknown in the majority of cases. Current…”
Get full text
Journal Article -
2
Altered Gut Microbiota in a Fragile X Syndrome Mouse Model
Published in Frontiers in neuroscience (26-05-2021)“…The human gut microbiome is the ecosystem of microorganisms that live in the human digestive system. Several studies have related gut microbiome variants to…”
Get full text
Journal Article -
3
Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice
Published in Scientific reports (22-10-2020)“…Fragile X syndrome (FXS), an X-chromosome linked intellectual disability, is the leading monogenetic cause of autism spectrum disorder (ASD), a…”
Get full text
Journal Article -
4
Neuroprotective role for RORA in Parkinson’s disease revealed by analysis of post-mortem brain and a dopaminergic cell line
Published in NPJ Parkinson's Disease (27-07-2023)“…Parkinson’s disease (PD) is almost twice as prevalent in men, which has largely been attributed to neuroprotective effect of oestradiol in women. RORA…”
Get full text
Journal Article -
5
Enhanced allele-specific PCR discrimination in SNP genotyping using 3′ locked nucleic acid (LNA) primers
Published in Human mutation (01-07-2003)“…The specificity and reliability of locked nucleic acid (LNA) substitution at the 3′ position of allele‐specific PCR (AS‐PCR) primers for SNP detection was…”
Get full text
Journal Article -
6
Microbiome alterations are associated with apolipoprotein E mutation in Octodon degus and humans with Alzheimer’s disease
Published in iScience (16-08-2024)“…Gut microbiome dysbiosis is linked to many neurological disorders including Alzheimer’s disease (AD). A major risk factor for AD is polymorphism in the…”
Get full text
Journal Article -
7
Genome Sequencing Variations in the Octodon degus , an Unconventional Natural Model of Aging and Alzheimer's Disease
Published in Frontiers in aging neuroscience (30-06-2022)“…The degu ( ) is a diurnal long-lived rodent that can spontaneously develop molecular and behavioral changes that mirror those seen in human aging. With age…”
Get full text
Journal Article -
8
Controlling the misuse of cobalt in horses
Published in Drug testing and analysis (01-01-2015)“…Cobalt is a well‐established inducer of hypoxia‐like responses, which can cause gene modulation at the hypoxia inducible factor pathway to induce…”
Get full text
Journal Article -
9
Bile acids and neurological disease
Published in Pharmacology & therapeutics (Oxford) (01-12-2022)“…This review will focus on how bile acids are being used in clinical trials to treat neurological diseases due to their central involvement with the…”
Get full text
Journal Article -
10
Design considerations and effects of LNA in PCR primers
Published in Molecular and cellular probes (01-10-2003)“…The effects of comprehensive LNA substitution in PCR primers for amplification of human genomic DNA targets are presented in this report. Previous research…”
Get full text
Journal Article -
11
Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome mice
Published in Brain (London, England : 1878) (29-03-2022)“…Fragile X syndrome is the most common inherited intellectual disability and mono-genetic cause of autism spectrum disorder. It is a neurodevelopmental…”
Get full text
Journal Article -
12
The long-lived Octodon degus as a rodent drug discovery model for Alzheimer's and other age-related diseases
Published in Pharmacology & therapeutics (Oxford) (01-08-2018)“…Alzheimer's disease (AD) is a multifactorial progressive neurodegenerative disease. Despite decades of research, no disease modifying therapy is available and…”
Get full text
Journal Article -
13
Voltage-gated calcium channels and Parkinson's disease
Published in Pharmacology & therapeutics (Oxford) (01-03-2012)“…A complex interaction of environmental, genetic and epigenetic factors combine with ageing to cause the most prevalent of movement disorders Parkinson's…”
Get full text
Journal Article -
14
Preface. Omic Studies of Neurodegenerative Disease: Part A
Published in International review of neurobiology (2015)Get more information
Journal Article -
15
Sampling Almonds for Aflatoxin, Part I: Estimation of Uncertainty Associated with Sampling, Sample Preparation, and Analysis
Published in Journal of AOAC International (01-07-2006)“…Domestic and international regulatory limits have been established for aflatoxin in almonds and other tree nuts. It is difficult to obtain an accurate and…”
Get full text
Journal Article -
16
NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome
Published in Neuromolecular medicine (01-03-2015)“…Fragile X syndrome (FXS) is the most common form of inherited intellectual disability. Previous studies have implicated mGlu5 in the pathogenesis of the…”
Get full text
Journal Article -
17
Calcium CaV1 Channel Subtype mRNA Expression in Parkinson’s Disease Examined by In Situ Hybridization
Published in Journal of molecular neuroscience (01-03-2015)“…The factors which make some neurons vulnerable to neurodegeneration in Parkinson’s disease while others remain resistant are not fully understood. Studies in…”
Get full text
Journal Article -
18
α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept study
Published in Brain communications (01-11-2023)“…Abstract Caudo-rostral migration of pathological forms of α-synuclein from the gut to the brain is proposed as an early feature in Parkinson’s disease…”
Get full text
Journal Article -
19
Multiplex allele-specific PCR with optimized locked nucleic acid primers
Published in BioTechniques (01-06-2003)Get full text
Journal Article -
20
Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson’s Disease
Published in Journal of molecular neuroscience (01-09-2015)“…Neuroinflammation is thought to contribute to cell death in neurodegenerative disorders, but the factors involved in the inflammatory process are not…”
Get full text
Journal Article